Condensed Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Income Statement [Abstract] | ||||||
| Revenues | $ 2,705,461 | $ 2,367,227 | $ 7,652,813 | $ 7,503,940 | $ 9,929,629 | $ 11,916,482 |
| Costs of goods sold | 903,834 | 769,956 | 2,529,018 | 2,444,401 | 3,269,967 | 4,685,639 |
| Gross Profit | 1,801,627 | 1,597,271 | 5,123,795 | 5,059,539 | 6,659,662 | 7,230,843 |
| Operating Expenses | ||||||
| Direct operating cost | 359,044 | 266,746 | 1,010,624 | 841,974 | 1,142,596 | 1,455,450 |
| Advertising costs | 114,795 | 57,195 | 402,229 | 190,588 | 270,709 | 105,672 |
| Selling and marketing | 599,306 | 636,643 | 1,792,337 | 1,620,109 | 2,206,091 | 1,094,628 |
| Research and development | 96,650 | 242,697 | 404,108 | 806,851 | 982,684 | 1,241,265 |
| General and administrative | 1,727,550 | 1,901,516 | 5,609,510 | 6,759,135 | 8,478,947 | 9,037,794 |
| Other expense | 101,013 | 54,296 | 254,770 | 133,261 | 147,506 | 374,389 |
| Goodwill impairment | 7,815,000 | |||||
| Depreciation and amortization | 402,821 | 217,767 | 1,126,346 | 649,468 | 944,596 | 828,137 |
| Total Operating Expenses | 3,401,179 | 3,376,860 | 10,599,924 | 11,001,386 | 21,988,129 | 14,137,335 |
| Operating Loss | (1,599,552) | (1,779,589) | (5,476,129) | (5,941,847) | (15,328,467) | (6,906,492) |
| Other Income | ||||||
| Interest income | 41,109 | 88,975 | 134,286 | 149,914 | 221,871 | 119,483 |
| Other income | 39,638 | 246,138 | 39,638 | 246,138 | 246,138 | |
| Total Other Income | 80,747 | 335,113 | 173,924 | 396,052 | 468,009 | 119,483 |
| Loss before Income Taxes | (1,518,805) | (1,444,476) | (5,302,205) | (5,545,795) | (14,860,458) | (6,787,009) |
| Income tax expense | (309,849) | 137,956 | ||||
| Net Loss | (1,518,805) | (1,444,476) | (5,302,205) | (5,545,795) | (14,550,609) | (6,924,965) |
| Preferred stock dividends | (75,000) | (75,000) | (225,000) | (225,000) | (300,000) | (328,456) |
| Deemed dividend | (930,122) | |||||
| Net Loss Attributable to Common Stockholders | $ (1,593,805) | $ (1,519,476) | $ (5,527,205) | $ (5,770,795) | $ (15,780,731) | $ (7,253,421) |
| Net Loss Attributable to Common Stockholders Per Share - Basic (in Dollars per share) | $ (0.2) | $ (1.1) | $ (1.34) | $ (4.73) | $ (11.66) | $ (15.15) |
| Net Loss Attributable to Common Stockholders Per Share - Diluted (in Dollars per share) | $ (0.2) | $ (1.1) | $ (1.34) | $ (4.73) | $ (11.66) | $ (15.15) |
| Weighted Average Number of Common Shares Outstanding - Basic (in Shares) | 7,995,555 | 1,380,373 | 4,112,228 | 1,219,749 | 1,353,333 | 478,705 |
| Weighted Average Number of Common Shares Outstanding - Diluted (in Shares) | 7,995,555 | 1,380,373 | 4,112,228 | 1,219,749 | 1,353,333 | 478,705 |
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. No definition available.
|
| X | ||||||||||
- Definition Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|